- Price
- $10.75
- Day
- 0.00%
- Mkt Cap
- $1.54B
- 52W Range
- $7.71 – $15.48
- Volume
- 413.4K
- Beta
- 0.70
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended June 30, 2026. Second Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key oper.
Read full article
Ardent Health, Inc. (ARDT) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.52 per share a year ago.
Read full article
Ardent Health, Inc. (ARDT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced that its physicians and advanced practice providers have surpassed 1 million patient encounters supported by Ambience Healthcare's ambient AI platform, marking a significant milestone in the organization's efforts to reduce clinician burnout, improve the provider experience and strengthen patient care. Ardent-affiliated clinicians using Ambience leverage the technology in 87% of ambulatory encounters across specialtie.
Read full article
PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Ardent Health, Inc. (NYSE: ARDT) (“Ardent”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/ardent/ Recently a securities fraud complaint was filed against Ardent on behalf of certain investors who purchased shares of the company's stock between July 18, 2024 and November 12, 2025 (the “Wrongdoing Period”). According to the com.
Read full article
Investor litigation firm [url="]Kaskela Law[/url] announces that it is investigating Ardent Health, Inc. (NYSE: ARDT) (âArdentâ) on behalf of the company's
Read full article
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its second quarter 2026 results after the market closes on Tuesday, August 4, 2026. A conference call will be held the following day, Wednesday, August 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying pr.
Read full article